Skip to main content

Percutaneous Lung Thermal Ablation of Non-surgical Clinical N0 Non-small Cell Lung Cancer: Results of Eight Years’ Experience in 87 Patients from Two Centers

CardioVascular and Interventional Radiology volume 38, pages 160–166 (2015)Cite this article

Abstract

Purpose

To evaluate the survival outcomes of percutaneous thermal ablation (RFA + microwaves) for patients presenting N0 non-small-cell lung cancer (NSCLC) ineligible for surgery.

Materials and Methods

Eighty-seven patients from two comprehensive cancer centers were included. Eighty-two patients were treated with RFA electrodes and five with microwave antenna. Overall survival (OS) and disease-free survival (DFS) were estimated and predictive factors of local tumor progression, OS and DFS identified and compared by univariate and multivariate analyses

Results

Median follow-up was 30.5 months (interquartile range 16.7–51) and tumor size was 21 mm (range 10–54 mm). Treatment was incomplete for 14 patients with a local tumor progression of 11.5, 18.3, and 21.1 % at 1, 2, and 3 years, respectively. Two patients presented with neurological (grade III or IV) complications, and one died of respiratory and multivisceral failure as a result of the procedure at 29 days. In univariate analysis, increasing tumor size (P = 0.003) was the only predictive factor related to risk of local tumor progression. 5-year OS and DFS were 58.1 and 27.9 %, respectively. Sex (P = 0.044), pathology (P = 0.032), and tumor size >2 cm (P = 0.046) were prognostic factors for DFS. In multivariate analysis, pathology (P = 0.033) and tumor size >2 cm (P = 0.032) were independent prognostic factors for DFS.

Conclusions

Oversized and overlapping ablation of N0 NSCLC was well tolerated, effective, with few local tumor progressions, even over long-term follow-up. Increasing tumor size was the main prognostic factor linked to OS, DFS, and local tumor progression.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2

References

  1. Rami-Porta R, Ball D, Crowley J, Giroux DJ, Jett J, Travis WD et al (2007) The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 2(7):593–602

    PubMed  Article  Google Scholar 

  2. Rami-Porta R, Tsuboi M (2009) Sublobar resection for lung cancer. Eur Respir J 33(2):426–435

    CAS  PubMed  Article  Google Scholar 

  3. Raz DJ, Zell JA, Ou SH, Gandara DR, Anton-Culver H, Jablons DM (2007) Natural history of stage I non-small cell lung cancer: implications for early detection. Chest 132(1):193–199

    PubMed  Article  Google Scholar 

  4. Qiao X, Tullgren O, Lax I, Sirzen F, Lewensohn R (2003) The role of radiotherapy in treatment of stage I non-small cell lung cancer. Lung Cancer 41(1):1–11

    PubMed  Article  Google Scholar 

  5. Fakiris AJ, McGarry RC, Yiannoutsos CT, Papiez L, Williams M, Henderson MA et al (2009) Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study. Int J Radiat Oncol Biol Phys 75(3):677–682

    PubMed  Article  Google Scholar 

  6. Haasbeek CJ, Lagerwaard FJ, Antonisse ME, Slotman BJ, Senan S (2010) Stage I nonsmall cell lung cancer in patients aged> or= 75 years: outcomes after stereotactic radiotherapy. Cancer 116(2):406–414

    PubMed  Article  Google Scholar 

  7. Onishi H, Araki T, Shirato H, Nagata Y, Hiraoka M, Gomi K et al (2004) Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 101(7):1623–1631

    PubMed  Article  Google Scholar 

  8. Timmerman R, Paulus R, Galvin J, Michalski J, Straube W, Bradley J et al (2010) Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 303(11):1070–1076

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  9. Ambrogi MC, Fanucchi O, Cioni R, Dini P, De LA, Cappelli C et al (2011) Long-term results of radiofrequency ablation treatment of stage I non-small cell lung cancer: a prospective intention-to-treat study. J Thorac Oncol 6(12):2044–2051

    PubMed  Article  Google Scholar 

  10. Beland MD, Wasser EJ, Mayo-Smith WW, Dupuy DE (2010) Primary non-small cell lung cancer: review of frequency, location, and time of recurrence after radiofrequency ablation. Radiology 254(1):301–307

    PubMed  Google Scholar 

  11. Fernando HC, De HA, Landreneau RJ, Gilbert S, Gooding WE, Buenaventura PO et al (2005) Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates. J Thorac Cardiovasc Surg 129(3):639–644

    PubMed  Article  Google Scholar 

  12. Hiraki T, Gobara H, Iishi T, Sano Y, Iguchi T, Fujiwara H et al (2007) Percutaneous radiofrequency ablation for clinical stage I non-small cell lung cancer: results in 20 nonsurgical candidates. J Thorac Cardiovasc Surg 134(5):1306–1312

    PubMed  Article  Google Scholar 

  13. Lanuti M, Sharma A, Willers H, Digumarthy SR, Mathisen DJ, Shepard JA (2012) Radiofrequency ablation for stage I non-small cell lung cancer: management of locoregional recurrence. Ann Thorac Surg 93(3):921–927

    PubMed  Article  Google Scholar 

  14. Pennathur A, Luketich JD, Abbas G, Chen M, Fernando HC, Gooding WE et al (2007) Radiofrequency ablation for the treatment of stage I non-small cell lung cancer in high-risk patients. J Thorac Cardiovasc Surg 134(4):857–864

    PubMed  Article  Google Scholar 

  15. Simon CJ, Dupuy DE, DiPetrillo TA, Safran HP, Grieco CA, Ng T et al (2007) Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients. Radiology 243(1):268–275

    PubMed  Article  Google Scholar 

  16. Trotti A, Colevas AD, Setser A, Rusch V, Jaques D, Budach V et al (2003) CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 13(3):176–181

    PubMed  Article  Google Scholar 

  17. Rubins J, Unger M, Colice GL (2007) American College of Chest Physicians. Follow-up and surveillance of the lung cancer patient following curative intent therapy: ACCP evidence-based clinical practice guideline (2nd edition). Chest 132(3):355S–367S

    PubMed  Article  Google Scholar 

  18. de Baere T (2011) Lung tumor radiofrequency ablation: where do we stand? Cardiovasc Intervent Radiol 34(2):241–251

  19. Hiraki T, Sakurai J, Tsuda T, Gobara H, Sano Y, Mukai T, Hase S, Iguchi T, Fujiwara H, Date H, Kanazawa S (2006) Risk factors for local progression after percutaneous radiofrequency ablation of lung tumors: evaluation based on a preliminary review of 342 tumors. Cancer 107(12):2873–2880

    PubMed  Article  Google Scholar 

  20. Schoellnast H, Deodhar A, Hsu M, Moskowitz C, Nehmeh SA, Thornton RH et al (2012) Recurrent non-small cell lung cancer: evaluation of CT-guided radiofrequency ablation as salvage therapy. Acta Radiol 53(8):893–899

    PubMed  Article  Google Scholar 

  21. Kodama H, Yamakado K, Takaki H, Kashima M, Uraki J, Nakatsuka A, Takao M, Taguchi O, Yamada T, Takeda K (2012) Lung radiofrequency ablation for the treatment of unresectable recurrent non-small-cell lung cancer after surgical intervention. Cardiovasc Intervent Radiol 35(3):563–569

    PubMed  Article  Google Scholar 

  22. Grieco CA, Simon CJ, Mayo-Smith WW, DiPetrillo TA, Ready NE, Dupuy DE (2006) Percutaneous image-guided thermal ablation and radiation therapy: outcomes of combined treatment for 41 patients with inoperable stage I/II non-small-cell lung cancer. J Vasc Interv Radiol 17(7):1117–1124

    PubMed  Article  Google Scholar 

  23. Ambrogi MC, Fontanini G, Cioni R, Faviana P, Fanucchi O, Mussi A (2006) Biologic effects of radiofrequency thermal ablation on non-small cell lung cancer: results of a pilot study. J Thorac Cardiovasc Surg 131(5):1002–1006

    PubMed  Article  Google Scholar 

  24. Giraud P, Antoine M, Larrouy A, Milleron B, Callard P, De RY et al (2000) Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning. Int J Radiat Oncol Biol Phys 48(4):1015–1024

    CAS  PubMed  Article  Google Scholar 

  25. Yasui K, Kanazawa S, Sano Y, Fujiwara T, Kagawa S, Mimura H et al (2004) Thoracic tumors treated with CT-guided radiofrequency ablation: initial experience. Radiology 231(3):850–857

    PubMed  Article  Google Scholar 

  26. Cerfolio RJ, Bryant AS (2009) Survival of patients with true pathologic stage I non-small cell lung cancer. Ann Thorac Surg 88(3):917–922

    PubMed  Article  Google Scholar 

  27. Crabtree TD, Denlinger CE, Meyers BF, El NI, Zoole J, Krupnick AS et al (2010) Stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer. J Thorac Cardiovasc Surg 140(2):377–386

    PubMed  Article  Google Scholar 

Download references

Acknowledgments

We thank Pippa McKelvie-Sebileau and Jone Iriondo-Alberdi for medical editorial assistance.

Conflict of interest

Jean Palussiere declares no conflict of interest. Philippe Lagarde declares no conflict of interest. Anne Aupérin declares no conflict of interest. Frédéric Deschamps declares no conflict of interest. François Chomy declares no conflict of interest. Thierry de Baere declares no conflict of interest.

Statement of Informed Consent

Informed consent was obtained from all individual participants included in the study.

Statement of Human and Animal Rights

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Author information

Affiliations

  1. Department of Interventional Radiology, Institut Bergonié, Comprehensive Cancer Centre, 229 cours de l’Argonne, 33000, Bordeaux, France

    Jean Palussiere

  2. Radiation Oncology Department, Institut Bergonié, Comprehensive Cancer Center, 229 cours de l’Argonne, 33000, Bordeaux, France

    Philippe Lagarde

  3. Unit of Biostatistics and Epidemiology, Institut Gustave-Roussy, 94805, Villejuif Cedex, France

    Anne Aupérin

  4. Department of Interventional Radiology, Institut Gustave-Roussy, 94805, Villejuif Cedex, France

    Frédéric Deschamps & Thierry de Baere

  5. Department of medical oncology, Institut Bergonié, Comprehensive Cancer Center, 229 cours de l’Argonne, 33000, Bordeaux, France

    François Chomy

Authors
  1. Jean Palussiere
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Philippe Lagarde
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anne Aupérin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Frédéric Deschamps
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. François Chomy
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Thierry de Baere
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jean Palussiere.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 31 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Palussiere, J., Lagarde, P., Aupérin, A. et al. Percutaneous Lung Thermal Ablation of Non-surgical Clinical N0 Non-small Cell Lung Cancer: Results of Eight Years’ Experience in 87 Patients from Two Centers. Cardiovasc Intervent Radiol 38, 160–166 (2015). https://doi.org/10.1007/s00270-014-0999-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00270-014-0999-6

Keywords

  • Interventional oncology
  • Non-vascular Interventions
  • Clinical practice
  • Radiofrequency ablation
  • Lung
  • Cancer
  • Primary lung cancer